Whittaker Clark Daniels Bankruptcy

In re Whittaker Clark & Daniels
Court	U.S. Court of Appeals, Third Circuit (precedential)
Dockets	Nos. 24-2210 & 24-2211 (consolidated); No. 25-1044
Argued	April 1, 2025
Decided	September 10, 2025
Panel	Krause, Matey, Ambro (opinion by Ambro; Krause concurring)
Appellants	Peter Protopapas (Receiver); Official Committee of Talc Claimants
On appeal from	D.N.J. (Judge Quraishi); Bankr. D.N.J. (Judge Kaplan)
Disposition	Affirmed
Key holding	Product-line successor-liability claims are property of the bankruptcy estate (11 U.S.C. § 541)

Executive Summary

In re Whittaker Clark & Daniels, Inc. is a precedential decision issued by the United States Court of Appeals for the Third Circuit on September 10, 2025 (argued April 1, 2025), in consolidated appeals Nos. 24-2210, 24-2211, and 25-1044. The case arose from the Chapter 11 bankruptcy of Whittaker Clark & Daniels — a company the court described as "distributing asbestos-contaminated talc" — which faced roughly 2,700 asbestos personal-injury suits, many for mesothelioma. The ruling is one of the most consequential recent appellate decisions for how victims of talc-asbestos exposure recover when a talc supplier enters bankruptcy.

The court resolved two questions. First, it held that Whittaker's board retained lawful authority to file for bankruptcy despite a South Carolina receivership, and clarified that an improperly filed petition is "cause" to dismiss but is not a jurisdictional defect. Second — and more consequentially — it held that the "product-line" successor-liability claims that talc claimants sought to pursue against Whittaker's asset-buyer, Brenntag, are property of the bankruptcy estate under 11 U.S.C. § 541, not personal claims belonging to individual plaintiffs.

The practical effect is that an approximately $535 million settlement Brenntag agreed to pay can move forward, with the proceeds flowing into the bankruptcy estate for distribution to creditors — a large, preserved recovery pool for asbestos victims — rather than to individual plaintiffs suing piecemeal. Because the company that controls the Debtors (Berkshire Hathaway) also backstops the settlement, the court emphasized that bankruptcy courts must rigorously scrutinize the deal under Bankruptcy Rule 9019 — a safeguard for claimants. For patients and families, the decision changes who controls the claims and how compensation is distributed; it underscores why experienced asbestos counsel matters when a defendant's liabilities are routed through a bankruptcy. Speak with a mesothelioma attorney to understand how a ruling like this affects your options.

At a Glance

In re Whittaker Clark & Daniels at a glance:

• Precedential Third Circuit ruling, September 10, 2025 — consolidated Nos. 24-2210, 24-2211, 25-1044; argued April 1, 2025; authored by Judge Ambro (panel of Judges Krause, Matey, and Ambro, with Judge Krause concurring).
• ~2,700 asbestos personal-injury suits had been filed against the Debtors over asbestos-contaminated talc, many alleging mesothelioma.
• ~$535 million Brenntag settlement preserved — the ruling clears the way for the settlement to fund the estate for distribution to claimants; the figure includes $50 million in Berkshire Hathaway debtor-in-possession financing.
• Product-line successor-liability claims = property of the estate under 11 U.S.C. § 541(a)(1), following In re Emoral and In re Wilton Armetale.
• Trustee/debtor-in-possession holds exclusive authority over those estate claims under 11 U.S.C. § 323 — individuals can no longer prosecute them independently.
• Improperly filed petition is "cause" to dismiss, not jurisdictional — an improper filing does not strip the bankruptcy court of subject-matter jurisdiction, resolving a previously unsettled question.
• Foreign receiver could not displace the board — a South Carolina receiver would have needed ancillary receivership recognition in New Jersey to control a New Jersey corporation's decision to file.
• Insider settlement, rigorous review — as debtors-in-possession, the Debtors owe fiduciary duties to all creditors, and courts scrutinize a settlement with an insider especially closely.
• "Plead-around" rejected — claimants cannot recharacterize estate claims as personal ones to escape the bankruptcy, citing In re Tronox.
• Purdue Pharma objection preserved — the court called the third-party-release argument premature, leaving it open for the plan-confirmation stage.
• Product-line successor liability — a strict-liability theory holding a company that acquires another's product line responsible for injuries from the predecessor's products (drawn from Ramirez v. Amsted Industries, N.J. 1981).

Key Facts

Item	Detail (Source)
Case	In re Whittaker Clark & Daniels, Inc., 3d Cir. Nos. 24-2210 & 24-2211, No. 25-1044 (Sept. 10, 2025), precedential
Lower courts	Bankr. D.N.J. (Judge Kaplan), In re Whittaker, Clark & Daniels, 663 B.R. 1 (Bankr. D.N.J. 2024); D.N.J. (Judge Quraishi) affirmed
Claimants	~2,700 asbestos personal-injury suits filed against the Debtors over asbestos-contaminated talc
Representative verdict	Sarah Plant — $29 million (South Carolina, March 2023), mesothelioma from asbestos-contaminated Whittaker talc
2004 asset sale	Whittaker, Brilliant and Soco sold substantially all operating assets to Brenntag North America; the Debtors agreed to indemnify Brenntag for legacy asbestos liabilities
Corporate parent	National Indemnity Co. (Berkshire Hathaway) acquired the Debtors and assigned its rights to Berkshire affiliate Ringwalt & Liesche Co., now the Debtors' ultimate parent
Settlement	Brenntag to pay ~$535 million to the estate (including $50 million Berkshire DIP financing) to release successor-liability claims; subject to Rule 9019 approval
Controlling statutes	11 U.S.C. § 541 (property of the estate); § 323 (trustee authority); § 1112(b) (cause to dismiss); § 158(d)(2) (direct appeal)

What was the Whittaker Clark & Daniels case about?

Whittaker Clark & Daniels, Inc. manufactured and distributed industrial chemicals and minerals, including talc the court described as "asbestos-contaminated." Over decades, that talc generated thousands of personal-injury claims. By the time of the bankruptcy, plaintiffs across the country had filed approximately 2,700 asbestos-related suits against the Debtors — many alleging mesothelioma. One representative case: Sarah Plant, who was diagnosed with mesothelioma after exposure to asbestos-contaminated Whittaker talc, won a $29 million jury verdict in South Carolina in March 2023.

In 2004, Whittaker and affiliated entities (Brilliant National Services and Soco West) sold substantially all of their operating assets to subsidiaries of Brenntag North America. Brilliant and Soco took on the obligation to indemnify Brenntag and its affiliates for legacy asbestos liabilities, and Whittaker continued on as a shell entity. Through later transactions, National Indemnity Company — a Berkshire Hathaway subsidiary — acquired the Debtors and now backstops the successor-liability exposure tied to Brenntag; National Indemnity assigned its acquisition rights to another Berkshire affiliate, Ringwalt & Liesche Co., which is now the Debtors' ultimate parent. That is why Berkshire-affiliated parties (Berkshire Hathaway, National Indemnity, and Ringwalt & Liesche) participated in the appeal as intervenors. With asbestos claims still pending, the Debtors filed for Chapter 11 in the District of New Jersey in 2023 and negotiated an approximately $535 million settlement with Brenntag — a deal that could not close until courts decided who actually controlled the successor-liability claims.

How did the case reach the Third Circuit?

The dispute traveled a layered path:

• South Carolina receivership. Days after the $29 million Plant verdict, a South Carolina court appointed Peter Protopapas as receiver over Whittaker. When Whittaker's board filed for bankruptcy over the receiver's objection, Protopapas moved to dismiss, arguing the board lacked authority to file.
• U.S. Bankruptcy Court, District of New Jersey (Judge Michael B. Kaplan). The court denied the motion to dismiss and, on summary judgment, held that the product-line successor-liability claims against Brenntag are property of the estate under 11 U.S.C. § 541(a)(1), following In re Emoral. It certified the questions for direct appeal under 28 U.S.C. § 158(d)(2). In re Whittaker, Clark & Daniels, 663 B.R. 1 (Bankr. D.N.J. 2024).
• U.S. District Court, District of New Jersey (Judge Zahid N. Quraishi). Affirmed the bankruptcy-authority ruling for substantially the same reasons.
• U.S. Court of Appeals for the Third Circuit. The consolidated appeals — brought by Protopapas (No. 24-2210) and the Official Committee of Talc Claimants (No. 24-2211), with the Brenntag adversary proceeding at No. 25-1044 — were argued April 1, 2025, and resolved in the precedential opinion filed September 10, 2025.

What did the Third Circuit hold?

The court affirmed, resolving the appeal on three points:

1. An improperly filed bankruptcy petition is not jurisdictional. An unauthorized petition is "cause" to dismiss under 11 U.S.C. § 1112(b), but it does not strip the bankruptcy court of subject-matter jurisdiction. Applying the Supreme Court's "clear statement" rule, the court resolved this previously unsettled question.
2. Whittaker's board properly filed for bankruptcy. The South Carolina receivership order did not — and could not, consistent with corporate-governance and choice-of-law principles — displace the board's authority to authorize a bankruptcy filing. To control the internal affairs of a New Jersey corporation, the South Carolina receiver would have had to seek ancillary receivership recognition in New Jersey, which he never did.
3. Product-line successor-liability claims are property of the estate under § 541. The claims talc claimants sought to assert against Brenntag belong to the Debtors' bankruptcy estates, applying and extending In re Emoral, 740 F.3d 875 (3d Cir. 2014), and In re Wilton Armetale, 968 F.3d 273 (3d Cir. 2020). Because those claims are estate property, the trustee/debtor-in-possession has exclusive authority to pursue, settle, and release them under 11 U.S.C. § 323.

The court declined to reach the bankruptcy court's alternative grounds (11 U.S.C. §§ 541(a)(7) and 544(a)(1)) because the § 541(a)(1) analysis was dispositive.

What does the ruling mean for talc-asbestos claimants?

The decision is best understood as centralizing recovery rather than ending it. Because the product-line claims are estate property, individual claimants can no longer separately prosecute or settle those particular claims against Brenntag — but the practical upside is that the approximately $535 million Brenntag settlement is preserved and channeled into the estate, where it forms a recovery pool to be distributed to creditors, including asbestos victims, often a larger and more orderly source of compensation than scattered individual suits.

A built-in safeguard protects claimants here. As debtors-in-possession, Whittaker and its affiliates owe fiduciary duties to all creditors, and because the entity backstopping the settlement (Berkshire's National Indemnity) also controls the Debtors, the settlement is an insider transaction that bankruptcy courts must review with heightened, "rigorous" scrutiny under Bankruptcy Rule 9019. The Bankruptcy Court held a trial on the settlement the week of March 3, 2025; whether the ~$535 million figure adequately values the successor-liability claims is the kind of question that review is designed to test, with the Official Committee of Talc Claimants able to be heard.

Two further features of the opinion matter for claimants going forward. The court rejected the idea that plaintiffs can "plead around" the bankruptcy by recasting estate claims as personal ones, quoting In re Tronox, 855 F.3d 84 (2d Cir. 2017). But it also held that the Committee's objection under Harrington v. Purdue Pharma L.P., 603 U.S. 204 (2024) — that treating the claims as estate property and releasing them would amount to a barred non-consensual third-party release — was premature, not meritless: that argument can be raised at the plan-confirmation stage, leaving claimants an avenue to be heard as the case proceeds. Finally, the "product-line" successor-liability theory at issue is a strict-liability rule — holding a business that acquires another's product line responsible for injuries caused by the predecessor's products — drawn from Ramirez v. Amsted Industries, 431 A.2d 811 (N.J. 1981); how it applies across the full body of claimants will be worked out as the bankruptcy proceeds.

If you or a family member has a talc-asbestos or mesothelioma claim touched by a corporate bankruptcy like this one, the path to compensation runs through the estate and any future trust — and the deadlines and procedures are unforgiving. Experienced asbestos counsel can preserve your place in that process.

How does this connect to asbestos bankruptcy trusts?

The opinion does not itself establish or administer a formal asbestos trust under 11 U.S.C. § 524(g) — the mechanism Congress created to channel asbestos claims through a dedicated trust. The Whittaker matter is an ordinary Chapter 11 case, and whether the ~$535 million is ultimately distributed through a § 524(g) channeling trust or a conventional Chapter 11 plan will be decided in later proceedings. The Official Committee of Talc Claimants — the statutory representative of talc creditors — will continue to represent claimants' interests as that distribution structure is built. For background on how these trusts pay victims, see Asbestos Trust Funds.

What this means for patients and families

In plain terms: when a company responsible for asbestos exposure goes bankrupt, the law often gathers the related claims together so that one large settlement can be shared fairly among everyone harmed, instead of a few early plaintiffs collecting while later victims get nothing. Here, that means the ~$535 million Brenntag settlement is protected and headed toward the people who were hurt — but it also means recovery happens through the bankruptcy estate and any future trust, on the court's schedule, not through a standalone lawsuit against the buyer.

A few practical takeaways:

• Your claim still has value. Being routed through a bankruptcy estate or trust is a normal, established path to compensation, not a dead end.
• Deadlines are strict. Bankruptcy bar dates and trust filing deadlines are separate from court statutes of limitations and can come quickly.
• Documentation matters. Diagnosis records, work and product-exposure history, and proof of which products caused exposure all strengthen a claim.
• Counsel matters. These cases turn on procedure — who controls the claim, which deadline applies, how the trust distributes — where experienced asbestos attorneys add the most value.

Frequently Asked Questions

Did talc-asbestos victims lose their claims in this ruling? No. The Third Circuit held that certain successor-liability claims against Brenntag belong to the bankruptcy estate rather than to individuals — which preserves the ~$535 million Brenntag settlement and channels it to victims through the estate, rather than extinguishing recovery.

What is the $535 million settlement? Brenntag, which bought Whittaker's assets in 2004, agreed to pay approximately $535 million to the Debtors' estate in exchange for release of successor-liability claims; that figure includes $50 million in Berkshire Hathaway debtor-in-possession financing approved in October 2024. The Third Circuit's ruling clears the way for the settlement, subject to Bankruptcy Court approval under Rule 9019.

What is "product-line successor liability"? It is a strict-liability theory under which a company that buys another's product line can be held responsible for injuries caused by the predecessor's products (a rule drawn from Ramirez v. Amsted Industries, N.J. 1981). The court held these particular claims are property of the bankruptcy estate, so the trustee — not individual plaintiffs — controls them.

Can claimants still object as the case continues? Yes. The court left open the Purdue Pharma argument about non-consensual third-party releases for the plan-confirmation stage, and any insider settlement remains subject to rigorous Rule 9019 review — both preserving avenues for claimant objections later in the bankruptcy.

Is this the same as a § 524(g) asbestos trust? Not yet. The opinion does not create a § 524(g) trust; whether one is established will be decided in future proceedings. See Asbestos Trust Funds for how such trusts work.

Quick Statistics

• September 10, 2025 — date of the precedential Third Circuit opinion (argued April 1, 2025).
• ~2,700 — asbestos personal-injury suits filed against the Debtors.
• ~$535 million — Brenntag settlement preserved by the ruling (includes $50 million Berkshire DIP financing).
• $50 million — Berkshire Hathaway debtor-in-possession financing, approved October 15, 2024.
• $29 million — Sarah Plant's 2023 South Carolina mesothelioma verdict.
• 3 — consolidated docket numbers (24-2210, 24-2211, 25-1044).

External Links

If you or a loved one was diagnosed with mesothelioma or another asbestos-related disease from talc exposure, your right to compensation can be affected by corporate bankruptcies like this one — and the deadlines are strict. The attorneys at Danziger & De Llano offer free, no-obligation consultations and help families pursue every available avenue, including asbestos trust claims and civil litigation. Learn more at the Mesothelioma Lawyer Center. Call (855) 699-5441 to speak with someone today.

Related Pages

• Asbestos Trust Funds
• Talc and Mesothelioma
• Mesothelioma Lawsuit
• Asbestos Bankruptcy Trusts
• Mesothelioma Settlements and Verdicts